Anti-CD3E Therapeutic Antibody (Visilizumab)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-714 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD3 receptor |
| Species Reactivity | Human |
| Type | IgG2 |
| Applications | Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods. |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |